Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Jazz Pharmaceuticals plc shares valued at $152,703 were sold by Henderson Mary Elizabeth on Sep 06 ’24. At $108.30 per share, Henderson Mary Elizabeth sold 1,410 shares. The insider’s holdings dropped to 14,531 shares worth approximately $1.57 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Henderson Mary Elizabeth purchased 2,691 shares, netting a total of over 296,010 in proceeds.
Before that, Winningham Rick E had added 3,075 shares to its account. In a trade valued at $341,325, the Director bought Jazz Pharmaceuticals plc shares for $111.00 each.
As published in their initiating research note from Goldman on June 05, 2024, Jazz Pharmaceuticals plc [JAZZ] has been a Buy and the price target has been revised to $169. Analysts at Robert W. Baird started covering the stock with ‘”an Outperform”‘ outlook in a report released in early January. As of November 27, 2023, UBS has decreased its “Buy” rating to a “Neutral” for JAZZ. Earlier on September 29, 2023, Raymond James initiated its rating. Their recommendation was “a Mkt perform” for JAZZ stock.
Analyzing JAZZ Stock Performance
During the last five days, there has been a drop of approximately -5.74%. Over the course of the year, Jazz Pharmaceuticals plc shares have dropped approximately -12.15%. Shares of the company reached a 52-week high of $134.17 on 02/26/24 and a 52-week low of $99.06 on 07/10/24. A 50-day SMA is recorded $110.89, while a 200-day SMA reached $113.28. Nevertheless, trading volume fell to 0.53 million shares from 0.34 million shares the previous day.
Support And Resistance Levels for Jazz Pharmaceuticals plc (JAZZ)
According to the 24-hour chart, there is a support level at 106.60, which, if violated, would cause prices to drop to 105.15. In the upper region, resistance lies at 110.34. The next price resistance is at 112.63. RSI (Relative Strength Index) is 42.44 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.61, which suggests the price will decrease in the coming days. Percent R is at 85.23%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
